Longevity Baseline

A 47-biomarker panel targeting the biological processes that influence ageing and long-term disease risk. Covers metabolic health, cardiovascular markers, nutrient status, organ function, and inflammation — serving as a foundational data point for anyone beginning a longevity-focused health strategy.

The Longevity Baseline panel is structured around the biomarker categories that ageing researchers have identified as most predictive of healthspan and disease risk. The metabolic component (fasting glucose, HbA1c, lipid studies) assesses the two biggest drivers of age-related decline: glucose dysregulation and cardiovascular disease. High-sensitivity CRP provides a snapshot of systemic inflammation — now recognised as a central mechanism in virtually every chronic disease from heart disease to neurodegeneration. Liver and kidney function markers detect organ stress that may be subclinical, while minerals (calcium, magnesium, phosphate) and vitamin D round out the nutritional assessment. Optional add-ons for vitamin B12, folate, zinc, and fasting insulin allow personalisation without inflating the base price. Fasting insulin in particular is a powerful addition — it can reveal insulin resistance years before HbA1c becomes abnormal, providing a crucial early intervention window. This panel establishes the baseline measurements that make longitudinal health tracking meaningful. Without knowing your starting point, future tests lack context for interpreting trends.